Interactions between cells of differing embryonic origins comprise a common theme during tissue development and repair. Often, communication between them can be mediated by soluble growth mediators and in some cases is restricted in focus. That is, some cells respond to, but do not produce, mediators expressed by other cells within the tissue. Because keratinocytes respond to but do not express insulin-like growth factor I (IGF-I), another skin cell population, the dermal fibroblast, may supply this factor. However, keratinocytes express, but do not respond to parathyroid hormone related protein (PTHrp), which increases cAMP production by dermal fibroblasts. Based on earlier results where inducers of cAMP increase local IGF-I expression in skeletal tissue, we postulated that PTHrp might induce local IGF-I by dermal fibroblasts and provide a source of this factor for keratinocyte activity. Our studies reveal that IGF-I mRNA and protein levels increase in response to PTHrp in vitro, and that this effect is replicated by inducers of cAMP, but not by activators of protein kinase C. Consequently, these factors appear to comprise a paracrine loop within the skin, permitting focused but restricted IGF-I expression to support skin growth, remodeling, or repair.Insulin-like growth factor-I (IGF-I) 1 regulates a variety of actions in many somatic tissues (1). In skin, IGF-I induces keratinocyte replication and skin matrix protein synthesis (2). However, keratinocytes do not express detectable amounts of IGF-I and may rely on the circulation, or perhaps expression by other local skin cells, for a supply of this factor (3, 4). In contrast, keratinocytes express another growth regulator, parathyroid hormone-related protein (PTHrp), which shares amino-terminal sequence homology with PTH and acts at least in part through conventional PTH receptors (5, 6). PTHrp was first purified from squamous cell tumors where it was implicated in the paraneoplastic syndrome, humoral hypercalcemia of malignancy. It is a highly conserved and ubiquitous protein with many effects in a broad range of tissues (reviewed in Refs. 6 and 7).Our earlier studies first demonstrated that IGF-I expression is enhanced by PTH, PTHrp, prostaglandin E 2 , and other inducers of cyclic adenosine monophosphate (cAMP) in osteoblasts (8 -10). Despite the assumption that skin, and dermis in particular, is not a primary target organ for PTH, receptors shared by PTH and PTHrp are clearly present on dermal fibroblasts (11-13) in which fibronectin synthesis increases after exposure to PTHrp (14). Therefore, we postulated that keratinocyte-derived PTHrp might act as a local regulator in skin in a manner similar to that by circulating PTH in the skeleton. In this study we asked specifically if PTHrp could increase IGF-I production by fetal dermal fibroblasts through a cAMP-dependent pathway. In this way, keratinocytes might support dermal fibroblast function through the action of PTHrp, and as a result dermal fibroblasts could support keratinocyte activity through an incr...